Smart pen cap could help tame blood sugar in type 1 diabetes

NCT ID NCT06845891

Completed Disease control Sponsor: Fernando Sebastián Valles Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a smart cap that attaches to insulin pens to help people with type 1 diabetes track their injections and glucose data. 42 adults used the device or a blinded version for comparison. The goal was to see if it reduces time spent with high blood sugar and improves overall glucose control.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Connected smart cap device for insulin pens
What this could lead to: If it works, this could help people with type 1 diabetes better manage their blood sugar and reduce complications.
What could go wrong: This is a small, single-center study with only 42 participants. The device is an add-on tool, not a cure, and results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MANAGEMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MANAGEMENT TYPE 1 DIABETES MELLITUS TYPE 1 DIABETES MELLITUS (T1DM)

Contacts and locations

Locations

Hospital Universitario de La Princesa

Madrid, Madrid, 28006, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.